| Name | Methyl Aminolevulinate Hydrochloride |
| Description | Methyl Aminolevulinate Hydrochloride (5-Aminolevulinic acid methyl ester) is commonly used in photosentizer reagents for photodynamic therapy to treat conditions such as Acne vulgaris and hypertrophic scarring. |
| In vivo | In mouse, Spermidine (200 μg) intracerebellar injection (icb), does not alter basal cGMP levels. Spermidine attenuates responses mediated through the NMDA, NMDA-associated glycine receptor and quisqualate receptors. Spermidine is widely distributed in neural and non-neural tissues and has been shown to play a key role in cell differentiation and growth [2]. |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 55 mg/mL (302.83 mM), Sonication is recommended.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (11.01 mM), Sonication is recommended.
|
| Keywords | vulgaris,?basal | therapy | sensitizer | Reactive Oxygen Species | photosensitiser | photodynamic | PDT,?acne | Methyl δ-aminolevulinate Hydrochloride | Methyl delta-aminolevulinate Hydrochloride | Methyl Aminolevulinate Hydrochloride | Methyl aminolevulinate | Inhibitor | inhibit | cell | carcinoma,?Metvix |
| Inhibitors Related | Ethoxyquin | Cysteamine hydrochloride | Acetylcysteine | Imeglimin hydrochloride | L-Ascorbic acid | Hesperidin | Glucosamine | Gallic Acid Monohydrate | L-Cystine | Coenzyme Q10 | L-Ascorbic acid sodium salt | Sodium 2-oxopropanoate |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Cosmetic Ingredient Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library |
United States
